STOCK TITAN

Omada Health (OMDA) CAO sells 2,083 shares in 10b5-1 plan trade

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4/A

Rhea-AI Filing Summary

Omada Health’s Chief Accounting Officer Craig Gracey reported an amended insider transaction showing a same-day option exercise and share sale. Gracey exercised 2,083 shares of Common Stock through a stock option with a $6.57 exercise price, then sold 2,083 shares in an open-market transaction at a weighted average price of $19.0118 per share.

The amendment corrects a prior Form 4 that reported the sale but inadvertently omitted the exercise, which had understated shares beneficially owned after the trade. Following the correction, Gracey directly holds 15,441 shares of Common Stock and 39,584 stock options that are exercisable at $6.57 and expire on October 23, 2034. The sale was executed under a Rule 10b5-1 trading plan adopted on March 13, 2026.

Positive

  • None.

Negative

  • None.
Insider Gracey Craig
Role Chief Accounting Officer
Sold 2,083 shs ($40K)
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) 2,083 $0.00 --
Exercise Common Stock 2,083 $6.57 $14K
Sale Common Stock 2,083 $19.0118 $40K
Holdings After Transaction: Stock Option (Right to Buy) — 39,584 shares (Direct, null); Common Stock — 17,524 shares (Direct, null)
Footnotes (1)
  1. This Form 4/A restates in its entirety the original Form 4 filed on 6/26/2026 to report exercise transaction that was inadvertently omitted from the original filing. The exercise reported herein was part of a same-day exercise-and-sale transaction, and the corresponding sale was timely reported in the original Form 4. Due to the omission of this exercise transaction, the amount of securities beneficially owned following the sale was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. This transaction was executed in multiple trades at prices ranging from $19.00 to $19.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. 25% of the shares subject to the option vested on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Shares sold 2,083 shares Common Stock sold in open-market transaction on June 24, 2026
Sale price $19.0118 per share Weighted average sale price for 2,083 common shares
Options exercise price $6.57 per share Exercise price for 2,083 stock options converted to common shares
Common shares held after 15,441 shares Directly owned Common Stock following corrected transactions
Options held after 39,584 options Stock Option (Right to Buy) remaining after exercising 2,083 options
Option expiration date October 23, 2034 Expiration for stock option grant with $6.57 exercise price
Rule 10b5-1 trading plan financial
"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
exercise-and-sale transaction financial
"The exercise reported herein was part of a same-day exercise-and-sale transaction"
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) listed as a derivative security"
weighted average price financial
"This transaction was executed in multiple trades...The price reported above reflects the weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
beneficially owned financial
"the amount of securities beneficially owned following the sale was understated"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Omada Health (OMDA) report for Craig Gracey?

Omada Health reported that Chief Accounting Officer Craig Gracey exercised 2,083 stock options at $6.57 and sold 2,083 common shares in an open-market trade at a weighted average price of $19.0118 per share, as part of a same-day exercise-and-sale transaction.

Why was this Omada Health (OMDA) Form 4/A filing amended?

The filing was amended because the original Form 4 omitted the option exercise tied to a same-day sale. Only the sale was reported initially, which understated the securities beneficially owned after the transaction. The amendment corrects Box 5 holdings to reflect the exercised shares accurately.

How many Omada Health (OMDA) shares did Craig Gracey sell and at what price?

Craig Gracey sold 2,083 shares of Omada Health common stock in an open-market transaction. The trades occurred between $19.00 and $19.03 per share, with a reported weighted average sale price of $19.0118 per share for the disclosed transaction.

What stock options did Craig Gracey exercise in Omada Health (OMDA)?

Gracey exercised a stock option covering 2,083 underlying Omada Health common shares at an exercise price of $6.57 per share. The option vests over four years from a September 9, 2024 vesting commencement date and is scheduled to expire on October 23, 2034.

What are Craig Gracey’s Omada Health (OMDA) holdings after this transaction?

After the corrected transactions, Craig Gracey directly holds 15,441 shares of Omada Health common stock and 39,584 stock options with a $6.57 exercise price. These option awards provide additional potential share ownership if exercised before their October 23, 2034 expiration date.

Was Craig Gracey’s Omada Health (OMDA) share sale pre-planned?

Yes. The filing states that the transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Craig Gracey on March 13, 2026. Such plans pre-schedule trades, indicating the timing of this sale was determined in advance rather than chosen opportunistically.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gracey Craig

(Last)(First)(Middle)
C/O OMADA HEALTH, INC.
611 GATEWAY BLVD, SUITE 120

(Street)
SOUTH SAN FRANCISCO CALIFORNIA 94080

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Accounting Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)
06/26/2026
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/24/2026M(1)2,083A$6.5717,524D
Common Stock06/24/2026S(2)2,083D$19.0118(3)15,441(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$6.5706/24/2026M(1)2,083 (4)10/23/2034Common Stock2,083$039,584D
Explanation of Responses:
1. This Form 4/A restates in its entirety the original Form 4 filed on 6/26/2026 to report exercise transaction that was inadvertently omitted from the original filing. The exercise reported herein was part of a same-day exercise-and-sale transaction, and the corresponding sale was timely reported in the original Form 4. Due to the omission of this exercise transaction, the amount of securities beneficially owned following the sale was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.
2. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
3. This transaction was executed in multiple trades at prices ranging from $19.00 to $19.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
4. 25% of the shares subject to the option vested on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
/s/ Nathan Salha, as Attorney-in-Fact for Craig Gracey07/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)